Abbott Laboratories [ABT] vs Dexcom [DXCM] Detailed Stock Comparison

Abbott Laboratories

NYSE

Dexcom

NASDAQ

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Abbott Laboratories wins in 18 metrics, Dexcom wins in 1 metrics, with 0 ties. Abbott Laboratories appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Abbott Laboratories	Dexcom	Better
P/E Ratio (TTM)	16.44	56.46	Abbott Laboratories
Price-to-Book Ratio	4.51	12.22	Abbott Laboratories
Debt-to-Equity Ratio	26.50	100.24	Abbott Laboratories
PEG Ratio	25.39	39.49	Abbott Laboratories
EV/EBITDA	20.53	33.67	Abbott Laboratories
Profit Margin (TTM)	32.43%	13.29%	Abbott Laboratories
Operating Margin (TTM)	19.73%	18.37%	Abbott Laboratories
EBITDA Margin (TTM)	19.73%	18.37%	Abbott Laboratories
Return on Equity	30.93%	22.83%	Abbott Laboratories
Return on Assets (TTM)	6.62%	6.08%	Abbott Laboratories
Free Cash Flow (TTM)	$6.35B	$630.70M	Abbott Laboratories
Dividend Yield	1.28%	N/A	N/A
1-Year Return	18.69%	8.44%	Abbott Laboratories
Price-to-Sales Ratio (TTM)	5.29	7.31	Abbott Laboratories
Enterprise Value	$235.08B	$31.09B	Abbott Laboratories
EV/Revenue Ratio	5.45	7.23	Abbott Laboratories
Gross Profit Margin (TTM)	56.44%	59.53%	Dexcom
Revenue per Share (TTM)	$25	$11	Abbott Laboratories
Earnings per Share (Diluted)	$7.97	$1.42	Abbott Laboratories
Beta (Stock Volatility)	0.71	1.44	Abbott Laboratories

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Abbott Laboratories vs Dexcom Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Abbott Laboratories	1.91%	-1.88%	0.20%	-1.20%	1.21%	16.14%
Dexcom	1.24%	2.65%	-4.52%	-5.51%	-10.58%	3.12%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Abbott Laboratories	18.69%	19.71%	28.66%	179.55%	456.61%	499.14%
Dexcom	8.44%	-4.89%	-24.15%	259.78%	2,494.55%	2,653.40%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Abbott Laboratories (ABT): View Full Stock Overview

Dexcom (DXCM): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Abbott Laboratories vs Dexcom

Metric	ABT	DXCM
Market Information
Market Cap i	$228.04B	$31.44B
Market Cap Category	Mega cap	Large cap
10 Day Avg. Volume i	5,619,133	5,083,030
90 Day Avg. Volume i	7,036,484	3,546,350
Last Close	$131.75	$80.95
52 Week Range	$109.76 - $141.23	$57.52 - $93.25
% from 52W High	-6.71%	-13.19%
All-Time High	$142.60 (Dec 27, 2021)	$164.86 (Nov 15, 2021)
% from All-Time High	-7.61%	-50.90%
Growth Metrics
Quarterly Revenue Growth	0.07%	0.15%
Quarterly Earnings Growth	0.37%	0.25%
Financial Health
Profit Margin (TTM) i	0.32%	0.13%
Operating Margin (TTM) i	0.20%	0.18%
Return on Equity (TTM) i	0.31%	0.23%
Debt to Equity (MRQ) i	26.50	100.24
Cash & Liquidity
Book Value per Share (MRQ)	$29.05	$6.56
Cash per Share (MRQ)	$4.18	$7.47
Operating Cash Flow (TTM) i	$9.04B	$987.70M
Levered Free Cash Flow (TTM) i	$5.92B	$425.12M
Dividends
Last 12-Month Dividend Yield i	1.28%	N/A
Last 12-Month Dividend i	$1.69	N/A

Valuation & Enterprise Metrics Analysis: Abbott Laboratories vs Dexcom

Metric	ABT	DXCM
Price Ratios
P/E Ratio (TTM) i	16.44	56.46
Forward P/E i	25.39	39.49
PEG Ratio i	25.39	39.49
Price to Sales (TTM) i	5.29	7.31
Price to Book (MRQ) i	4.51	12.22
Market Capitalization
Market Capitalization i	$228.04B	$31.44B
Enterprise Value i	$235.08B	$31.09B
Enterprise Value Metrics
Enterprise to Revenue i	5.45	7.23
Enterprise to EBITDA i	20.53	33.67
Risk & Other Metrics
Beta i	0.71	1.44
Book Value per Share (MRQ) i	$29.05	$6.56

Financial Statements Comparison: Abbott Laboratories vs Dexcom

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	ABT	DXCM
Revenue/Sales i	$10.36B	$1.04B
Cost of Goods Sold i	$4.47B	$447.00M
Gross Profit i	$5.89B	$589.00M
Research & Development i	$716.00M	$145.20M
Operating Income (EBIT) i	$1.69B	$133.70M
EBITDA i	$2.66B	$219.00M
Pre-Tax Income i	$1.78B	$154.30M
Income Tax i	$453.00M	$48.90M
Net Income (Profit) i	$1.33B	$105.40M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	ABT	DXCM
Cash & Equivalents i	$6.53B	$904.90M
Total Current Assets i	$23.15B	$4.55B
Total Current Liabilities i	$13.00B	$3.04B
Long-Term Debt i	$12.74B	$1.36B
Total Shareholders Equity i	$49.06B	$2.27B
Retained Earnings i	$47.72B	$1.70B
Property, Plant & Equipment i	N/A	$59.10M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	ABT	DXCM
Operating Cash Flow i	$1.42B	$167.90M
Capital Expenditures i	$-484.00M	$-87.00M
Free Cash Flow i	$933.00M	$96.80M
Debt Repayment i	$-1.00B	N/A
Common Stock Repurchase i	$-280.00M	N/A

Short Interest & Institutional Ownership Analysis

Metric	ABT	DXCM
Shares Short i	18.33M	8.49M
Short Ratio i	2.44	2.71
Short % of Float i	0.01%	0.03%
Average Daily Volume (10 Day) i	5,619,133	5,083,030
Average Daily Volume (90 Day) i	7,036,484	3,546,350
Shares Outstanding i	1.73B	390.70M
Float Shares i	1.73B	389.43M
% Held by Insiders i	0.01%	0.00%
% Held by Institutions i	0.81%	0.99%

Dividend Analysis & Yield Comparison: Abbott Laboratories vs Dexcom

Metric	ABT	DXCM
Last 12-Month Dividend i	$1.69	N/A
Last 12-Month Dividend Yield i	1.28%	N/A
3-Year Avg Annual Dividend i	$1.92	N/A
3-Year Avg Dividend Yield i	0.49%	N/A
3-Year Total Dividends i	$5.77	N/A
Ex-Dividend Date	Jan 15, 2025	N/A

Abbott Laboratories [ABT] vs Dexcom [DXCM] Detailed Stock Comparison